Effect of obesity on overall survival in patients diagnosed with chronic myelomonocytic leukemia (CMML)

被引：0
|
作者：
Alfakara, Dima
Swedeh, Amer
Kaufman, Gregory
Patnaik, Mrinal M.
Hashmi, Sharukh
Hogan, William J.
Elliott, Michelle A.
Wolanskyj, Alexandra P.
Liu, Shujun
Litzow, Mark Robert
Al-Kali, Aref
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7064
引用
收藏
页数：1
相关论文
共 50 条
  • [1] HYPOMETHYLATING AGENTS DOES NOT IMPROVE OVERALL SURVIVAL IN PATIENTS DIAGNOSED WITH CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) COMPARED TO HISTORICAL DATA
    Affakara, D.
    Hanson, C.
    Swedeh, A.
    Elliott, M.
    Hashmi, S.
    Wolanskyj, A.
    Hogari, W.
    Litzow, M.
    Al-Kali, A.
    HAEMATOLOGICA, 2013, 98 : 88 - 88
  • [2] PROGNOSTIC FACTORS AND SURVIVAL IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
    STARK, AN
    THOROGOOD, J
    HEAD, C
    ROBERTS, BE
    SCOTT, CS
    BRITISH JOURNAL OF CANCER, 1987, 56 (01) : 59 - 63
  • [3] Chronic myelomonocytic leukemia (CMML)
    Geissler, Klaus
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2023, 173 (1-2) : 1 - 2
  • [4] Chronic myelomonocytic leukemia (CMML)
    Klaus Geissler
    Wiener Medizinische Wochenschrift, 2023, 173 : 1 - 2
  • [5] CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PATIENTS WITH LYSOZYME NEPHROPATHY AND CMML RENAL
    Lafargue, Marie-Camille
    Van Huyen, Jean-Paul Duong
    Isnard, Pierre
    Rennke, Helmut
    Essig, Marie
    Carre, Martin
    Mercadal, Lucile
    Farhi, Jonathan
    Bobot, Mickael
    Sakhi, Hamza
    Comont, Thibault
    Golbin, Leonard
    Chemouny, Jonathan
    Cambier, Nathalie
    Laribi, Kamel
    Selamet, Umut
    Riella, Leonardo
    Fain, Olivier
    Ades, Lionel
    Fenaux, Pierre
    Cohen, Camille
    Mekinian, Arsene
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I380 - I381
  • [6] DECITABINE AS COMPARED TO AZACITIDINE THERAPY MAY RESULT IN BETTER OVERALL SURVIVAL BUT NOT QUALITY OF LIFE IN PATIENTS DIAGNOSED WITH CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML): A RETROSPECTIVE, SINGLE I
    Al-Kali, A.
    Hashmi, S.
    Alsahlawi, A.
    Patnaik, M.
    Elliott, M.
    Wolanskyj, A.
    Hogan, W.
    Siddiqui, M.
    Litzow, M.
    HAEMATOLOGICA, 2014, 99 : 612 - 612
  • [7] Incidence and survival of chronic myelomonocytic leukemia (CMML) in the United States (US).
    Murthy, Guru Subramanian Guru
    Venkitachalam, Raji
    Bhatt, Vijaya Raj
    Dhakal, Ishwori
    Lee, Jeanette Y.
    Jethava, Yogesh
    Mehta, Paulette
    Emanuel, Peter D.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [8] AZACITIDINE IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML): POSSIBILITY OF IMPROVED RESPONSE AND SURVIVAL
    Niscola, P.
    Tendas, A.
    Cupelli, L.
    Piccioni, D.
    Giovannini, M.
    Scaramucci, L.
    Abruzzese, E.
    Caravita, T.
    Dentamaro, T.
    Morino, L.
    Neri, B.
    Renzi, D.
    Siniscalchi, A.
    Trawinska, M. M.
    de Fabritiis, P.
    HAEMATOLOGICA, 2015, 100 : 727 - 727
  • [9] Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML).
    Wijermans, P. W.
    Luebbert, Michael
    Baer, Maria R.
    Slack, James L.
    BLOOD, 2006, 108 (11) : 756A - 757A
  • [10] PREDICTIVE FACTORS FOR EVOLUTION FROM OLIGOMONOCYTIC CHRONIC MYELOMONOCYTIC LEUKEMIA (OM-CMML) TO CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
    Bravo David, Roman
    Rocha Leonor, Arenillas
    Maria Teresa, Asensi
    Nieves, Garcia-Gisbert
    Juan Jose, Rodriguez Sevilla
    Ruiz Brayan, Merchan
    Avila Sara, Garcia
    Paricio Beatriz, Bellosillo
    Maria Concepcion, Fernandez-Rodriguez
    Brichs Lourdes, Florensa
    del Alamo Ana, Ferrer
    Gonzalez Xavier, Calvo
    HAEMATOLOGICA, 2021, 106 (10) : 252 - 252
12345